Mechanism difference Semaglutide (GLP-1 agonist): appetite regulation, satiety, improved glycemic control (New England Journal of Medicine) Tirzepatide (GLP-1/GIP agonist): broader incretin effects, robust appetite/weight effects (New England Journal of Medicine) AOD-9604: targeted fat-metabolism signaling
Check Your Local Suppliers If you want to know more about our product (or) need help with finding your supplier
Animal studies suggest that semaglutide does pass into breast milk in lactating rats
And now, of course, we have much better drug therapy and much better drug delivery devices like insulin pumps
Our Precision Peptide Genetic Test may help provide context on your individual peptide pathway factorsincluding GIPR, and FTO variantsto support a more personalized conversation with your provider about which compounded GLP-1 formulation or dual-compound protocol may align best with your metabolic profile
Dark Spot Daily Defense Combo send home with clients for daily brightening and SPF maintenance